Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 14;12(10):1615.
doi: 10.3390/genes12101615.

Disruptive NADSYN1 Variants Implicated in Congenital Vertebral Malformations

Affiliations

Disruptive NADSYN1 Variants Implicated in Congenital Vertebral Malformations

Jiachen Lin et al. Genes (Basel). .

Abstract

Genetic perturbations in nicotinamide adenine dinucleotide de novo (NAD) synthesis pathway predispose individuals to congenital birth defects. The NADSYN1 encodes the final enzyme in the de novo NAD synthesis pathway and, therefore, plays an important role in NAD metabolism and organ embryogenesis. Biallelic mutations in the NADSYN1 gene have been reported to be causative of congenital organ defects known as VCRL syndrome (Vertebral-Cardiac-Renal-Limb syndrome). Here, we analyzed the genetic variants in NADSYN1 in an exome-sequenced cohort consisting of patients with congenital vertebral malformations (CVMs). A total number of eight variants in NADSYN1, including two truncating variants and six missense variants, were identified in nine unrelated patients. All enrolled patients presented multiple organ defects, with the involvement of either the heart, kidney, limbs, or liver, as well as intraspinal deformities. An in vitro assay using COS-7 cells demonstrated either significantly reduced protein levels or disrupted enzymatic activity of the identified variants. Our findings demonstrated that functional variants in NADSYN1 were involved in the complex genetic etiology of CVMs and provided further evidence for the causative NADSYN1 variants in congenital NAD Deficiency Disorder.

Keywords: NADSYN1 gene; congenital NAD Deficiency Disorder; congenital vertebral malformation; exome sequencing.

PubMed Disclaimer

Conflict of interest statement

There is no competing interests to declare for all authors.

Figures

Figure 1
Figure 1
(A) Protein domain diagram of human NADSYN1 and the position of identified variants. The glutaminase domain is labeled in green, NAD synthetase domain in purple, P1 loop in yellow, P2 loop in pink, and ATP binding site in red, respectively. The RefSeq transcript sequence of NADSYN1 gene is NM_018161.5; PDB accession code: 6OFB. (B) Space distribution of variants in 3D model using Swiss-Model and PyMOL (https://pymol.org (accessed on 4 January 2021)). (C) Position of the variants (red) relative to an evolutionarily conserved region using ClustalW sequence alignment (https://www.genome.jp/tools-bin/clustalw (accessed on 8 April 2021)).
Figure 2
Figure 2
(A) Expression of NADSYN1 protein in cells transfected with wild type (WT) and mutant NADSYN1 plasmid. (B) The western blot shows the content of the NADSYN1 protein before and after protein purification. (C)Quantification of the NADSYN1 WT and mutant protein based on western blot results. Then band intensity was measured by ImageJ based on ImageJ software. (D) Nicotinamide adenine dinucleotide synthetase activity of purified mutant protein compared to wild-type (WT) NADSYN1 protein. Abbreviations: NC, negative control; ns, non-significant. The results are shown as the mean ± standard error of three independent experiments. p-Values < 0.05 (*), 0.0001 (****) were considered significant.

Similar articles

Cited by

References

    1. Wynne-Davies R. Congenital vertebral anomalies: Aetiology and relationship to spina bifida cystica. J. Med. Genet. 1975;12:280–288. doi: 10.1136/jmg.12.3.280. - DOI - PMC - PubMed
    1. Giampietro P.F., Dunwoodie S.L., Kusumi K., Pourquie O., Tassy O., Offiah A.C., Cornier A.S., Alman B.A., Blank R.D., Raggio C.L., et al. Progress in the understanding of the genetic etiology of vertebral segmentation disorders in humans. Ann. N. Y. Acad. Sci. 2009;1151:38–67. doi: 10.1111/j.1749-6632.2008.03452.x. - DOI - PubMed
    1. Furdock R., Brouillet K., Luhmann S.J. Organ System Anomalies Associated with Congenital Scoliosis: A Retrospective Study of 305 Patients. J. Pediatr. Orthop. 2019;39:e190–e194. doi: 10.1097/BPO.0000000000001279. - DOI - PubMed
    1. Pahys J.M., Guille J.T. What’s New in Congenital Scoliosis? J. Pediatr. Orthop. 2018;38:e172–e179. doi: 10.1097/BPO.0000000000000922. - DOI - PubMed
    1. Chen N., Zhao S., Jolly A., Wang L., Pan H., Yuan J., Chen S., Koch A., Ma C., Tian W., et al. Perturbations of genes essential for Mullerian duct and Wolffian duct development in Mayer-Rokitansky-Kuster-Hauser syndrome. Am. J. Hum. Genet. 2021;108:337–345. doi: 10.1016/j.ajhg.2020.12.014. - DOI - PMC - PubMed

Publication types

Substances

-